P. Di Napoli et al., Simvastatin reduces reperfusion injury by modulating nitric oxide synthaseexpression: an ex vivo study in isolated working rat hearts, CARDIO RES, 51(2), 2001, pp. 283-293
Citations number
54
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Objective: We tested the hypothesis of beneficial effects of the 3-hydroxy-
3-methyl-glutaryl coenzyme A (HMG-CoA)-reductase inhibitor simvastatin in a
model of ischemia-reperfusion, and investigated potential mechanisms. Meth
ods: Isolated working rat hearts were subjected to 15 min global ischemia a
nd 22-180 min reperfusion in the presence or absence of simvastatin (10-100
muM). We evaluated creatinephosphokinase and nitrite levels in coronary ef
fluent, heart weight changes, microvascular permeability (extravasation of
fluoresceine-labeled albumin), ultrastructural alterations, and the express
ion of endothelial (e) and inducible (i) nitric oxide synthase (NOS) (by re
verse-transcribed polymerase chain reaction and Western blotting) in the pr
esence or absence of the transcriptional inhibitor actinomycin-D. Results:
Simvastatin (25 muM) significantly reduced myocardial damage and vascular h
yperpermeability, concomitant with a reduction in endothelial and cardiomyo
cyte lesions. Protection became less evident at 50 muM and reverted to incr
eased damage at 100 muM. At 25 muM, simvastatin significantly increased eNO
S mRNA and protein compared with untreated hearts, probably due to a post-t
ranscriptional regulation since unaltered by animal pretreatment with actin
omycin D. Simvastatin also significantly decreased iNOS mRNA and protein, a
s well as nitrite production after ischemia-reperfusion. The addition of th
e NOS inhibitor N-w-nitro-L-arginine methylester (L-NAME, 30 muM) to 25 muM
simvastatin-treated hearts significantly reduced cardioprotection against
ischemia-reperfusion. Conclusions: In this model, in the absence of perfusi
ng granulocytes, the acute administration of a pharmacologically relevant s
imvastatin concentration reduces ischemia-reperfusion injury and prevents c
oronary endothelial cell and cardiomyocyte damage by cholesterol-independen
t, NO-dependent mechanisms. (C) 2001 Elsevier Science BY. All rights reserv
ed.